- ►annals.org [PDF] FA McAlister, JA Ezekowitz, N Wiebe, B … - Annals of internal …, 2004 - Am Coll Physicians Background: Even with optimal pharmacotherapy, symptomatic heart failure is associated with
substantial morbidity and mortal- ity. Purpose: To determine the efficacy and safety of cardiac
resyn- chronization therapy in adults with advanced systolic heart failure. Data Sources: ... Cited by 224 - Related articles - BL Direct - All 6 versions
D Sources, D Extraction, D Synthesis - Ann Intern Med, 2004 - muse.lib.nccu.edu.tw Background: Even with optimal pharmacotherapy, symptomatic heart failure is associated with
substantial morbidity and mortal- ity. Purpose: To determine the efficacy and safety of cardiac
resyn- chronization therapy in adults with advanced systolic heart failure. Data Sources: ... Related articles - View as HTML - All 3 versions
- ►onlinejacc.org SL Higgins, JD Hummel, IK Niazi, MC Giudici, SJ … - Journal of the American …, 2003 - Elsevier Patients (n = 490) were implanted with a device capable of providing both CRT and ICD therapy
and randomized to CRT (n = 245) or control (no CRT, n = 245) for up to six months. The primary
end point was progression of HF, defined as all-cause mortality, hospitalization for HF, ... Cited by 367 - Related articles - BL Direct - All 8 versions
- ►oxfordjournals.org [PDF] C Leclercq, S Walker, C Linde, J Clementy, AJ … - European heart …, 2002 - Eur Soc Cardiology European Heart Journal (2002) 23, 1780–1787 doi:10.1053/euhj.2002.3232, available online
at http://www.idealibrary.com on ... C. Leclercq 1 , S. Walker 2 , C. Linde 3 , J. Clementy 4 , AJ
Marshall 5 , P. Ritter 6 , ... P. Djiane 7 , P. Mabo 1 , T. Levy 2 , F. Gadler 3 , C. Bailleul 8 ... Cited by 285 - Related articles - BL Direct - All 3 versions
- ►annals.org [PDF] GM Leung, TH Rainer, FL Lau, IOL Wong, A … - Annals of internal …, 2004 - Am Coll Physicians Background: Even with optimal pharmacotherapy, symptomatic heart failure is associated with
substantial morbidity and mortal- ity. Purpose: To determine the efficacy and safety of cardiac
resyn- chronization therapy in adults with advanced systolic heart failure. Data Sources: ... Cited by 24 - Related articles - BL Direct - All 7 versions
DJ Bradley, EA Bradley, KL Baughman, RD Berger, H … - Jama, 2003 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do to make
your experience on this site better. ... Context Progressive heart failure is the most ... Cited by 674 - Related articles - BL Direct - All 13 versions
G Nichol, P Kaul, E Huszti, JFP Bridges - Annals of internal medicine, 2004 - Am Coll Physicians Background: Heart failure is a common, costly, and debilitating illness. Resynchronization of
ventricular contraction in patients with heart failure improves ejection fraction. The long-term
morbidity and costs associated with such cardiac resynchronization therapy remain unclear. Cited by 66 - Related articles - BL Direct - All 9 versions
JB Young, WT Abraham, AL Smith, AR Leon, R … - Jama, 2003 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do to make
your experience on this site better. ... Context Cardiac resynchronization therapy (CRT) ... Cited by 584 - Related articles - BL Direct - All 9 versions
A Auricchio, WT Abraham - Circulation, 2004 - Am Heart Assoc An overwhelming amount of evidence from prospective randomized controlled trials supports
the clinical efficacy and safety of cardiac resynchronization therapy (CRT) in patients with moderate
or severe heart failure and ventricular dyssynchrony. 1–6 As noted below, CRT makes ... Cited by 129 - Related articles - BL Direct - All 7 versions
- ►oxfordjournals.org … , MJ Calvert, WT Abraham, J Ghosh, JGF … - European Journal of …, 2006 - eurjhf.oxfordjournals.org Results: We identified 8 randomised trials which included 3380 patients and observed a total
of 524 deaths. Follow-up ranged from 1 month to a mean of 29.4 months. Most trials were of high
quality, with centrally administered randomisation and few patients lost to follow-up. CRT ... Cited by 68 - Related articles - All 5 versions
